INS and myocardial infarction: The DIGAMI (Diabetes Mellitus, Insulin–Glucose Infusion in Acute Myocardial Infarction) study provided evidence that intensive insulin treatment does not result in better cardiovascular outcomes compared with sulfonylurea therapy [102].